Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

According to BMO Capital Markets, Rybelsus’ outcomes in SOUL were “inconsistent,” failing to significantly lower ...

But keep in mind that if you have type 2 diabetes and heart disease, using Ozempic also reduces your risk of heart attack and stroke. And if you have chronic kidney disease, Ozempic can reduce ...

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

Stopping Ozempic injections for weight loss can cause weight gain and a possible increase in blood sugar and blood pressure. To restart Ozempic treatment, a doctor will slowly increase your dose ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...